Midstream Health, an autonomous financial operations platform designed for health systems, announced on Thursday that it has secured $20 million in Series A funding.
The company integrates contracts, claims, purchasing, pharmacy, and payment data, utilizing artificial intelligence to identify and prevent revenue loss. Its client portfolio includes major institutions such as CommonSpirit Health, Mount Sinai Health System, Houston Methodist, Fairview Health Services, and Keck Medicine of USC.
“We refer to it as the ‘second financial brain’ for a health system,” explained Sumit Kadakia, CEO and co-founder of Midstream Health. “Hospitals are multibillion-dollar enterprises, yet most lack any form of managerial finance.”
The Series A funding round was led by Valtruis, with participation from Andreessen Horowitz (a16z), Foundry, and CommonSpirit Ventures. To date, Midstream has raised a total of $29.2 million.
“In the current economic climate, health systems require solutions that can rapidly improve their financial standing,” said Mike Spadafore, managing director at Valtruis. “We are backing Midstream because it offers a first-of-its-kind infrastructure that transforms complex financial data into actionable insights. While enterprise healthcare technology solutions can take years to prove their worth, Midstream delivers tangible results within a single quarter.”
According to Kadakia, the new capital will be utilized to expand Midstream’s product and engineering capabilities. Additionally, the company plans to enhance its sales and marketing operations and establish a dedicated research division.
This funding announcement coincides with a period of significant financial strain, as over 110 rural hospitals have closed in the last two decades, with approximately 720 more facing potential closure. This is a deeply personal issue for Kadakia, whose father practiced at two rural hospitals in West Virginia that have since shut down.
“Health systems are losing margins they have already earned,” Kadakia noted. “A single health system can have thousands of contracts spanning supply chain, pharmacy, and managed care, each with unique pricing tiers, rebate triggers, and amendments. With no time to verify every contract against actual purchases and payments, a six-figure rebate can vanish due to a single missed form. While most healthcare AI investment has focused on the claims disputes between hospitals and insurers—where every dollar gained by one side is lost by the other, driving up overall care costs—Midstream focuses on internal optimization.”
Kadakia shared that Midstream is on track to achieve $100 million in client savings by the end of 2026. In the long term, the company aims to better enable value-based care models.
“Value-based care was established on an unstable foundation,” Kadakia explained. “To assume risk, a hospital requires a clear understanding of the actual costs of care and the underlying reasons, yet the necessary systems to provide this visibility were never developed. By providing hospitals with this foundational visibility, we enable them to take on more risk, which is the key to defusing the adversarial dynamic between payers and providers.”
Photo: Richard Drury, Getty Images
Also Read
- Setara Biosciences Launches With $90 Million Series A and Clinical-Stage Rare Disease Pipeline
- Valuing Lives: Why Listening to People with Learning Disabilities Is a Matter of Survival
- Harkla Recalls Over 25,500 Sensory Swings After Ceiling Hooks Detach, Injuring Children
- Rising Vaccine Acceptance Noted Amid Measles Outbreak in Pennsylvania Amish Communities
